Inflammatory markers and risk of cerebrovascular events in patients initiating dialysis. - Wikidata - wikimedia - TriplyDB

Inflammatory markers and risk of cerebrovascular events in patients initiating dialysis.

Inflammatory markers and risk of cerebrovascular events in patients initiating dialysis.

http://www.wikidata.org/entity/Q35030572

about

Evidence for the prevention and treatment of stroke in dialysis patients Ischemic stroke among the patients with end-stage renal disease who were undergoing maintenance dialysis Low serum fetuin A levels and incident stroke in patients with maintenance haemodialysis.

P2860

Q27023274-8B2795E7-2470-4BA5-801C-14D5F4F416A5 Q36178116-1288B077-F954-4ED0-ACE7-5C02343CFDC6 Q46138663-C6FC990F-7D0C-437D-B27D-E61C75E9884B

P2860

Inflammatory markers and risk of cerebrovascular events in patients initiating dialysis.

http://www.wikidata.org/entity/Q35030572

description

2011 nî lūn-bûn

@nan

2011 թուականի Մայիսին հրատարակուած գիտական յօդուած

@hyw

2011 թվականի մայիսին հրատարակված գիտական հոդված

@hy

2011年の論文

@ja

2011年論文

@yue

2011年論文

@zh-hant

2011年論文

@zh-hk

2011年論文

@zh-mo

2011年論文

@zh-tw

2011年论文

@wuu

name

Inflammatory markers and risk of cerebrovascular events in patients initiating dialysis.

@ast

Inflammatory markers and risk of cerebrovascular events in patients initiating dialysis.

@en

type

label

Inflammatory markers and risk of cerebrovascular events in patients initiating dialysis.

@ast

Inflammatory markers and risk of cerebrovascular events in patients initiating dialysis.

@en

prefLabel

Inflammatory markers and risk of cerebrovascular events in patients initiating dialysis.

@ast

Inflammatory markers and risk of cerebrovascular events in patients initiating dialysis.

@en

P1433

Q35030572-E884679E-B43A-4326-BCD8-E847FE26F905

P1476

Q35030572-276D296A-1705-4AE0-8F94-0C0F0D8C5A2B

P2093

Q35030572-7D1139DD-C16B-4FF4-B1D9-ABC5CDFD1DD0

Q35030572-8A1F2E74-BA10-4DAE-9555-0D8089F2A476

Q35030572-8E19C107-122B-41CF-9F5F-413C3CE1F090

Q35030572-990250A2-6FEE-4F3E-A229-83EC6D45A2E6

Q35030572-B9E443BE-1F9D-40CB-9D9F-FF970FBEAA95

Q35030572-FE891174-FD8E-46B7-A342-6827B910FCC0

P2860

Q35030572-077244E0-CC63-485F-A910-03BA951C0BD5

Q35030572-08C1B22E-0479-44D5-B6D9-C3E84C210194

Q35030572-212B96C7-D151-4ABD-BA01-C968D2EC46ED

Q35030572-21D2DF5A-AB66-4CBD-9F4A-C5B85A829996

Q35030572-2D44E610-EE95-4105-ADAB-21949A6993A5

Q35030572-420C9AA0-1ECD-47CC-8C71-8C0E988ADD79

Q35030572-450ABBC3-EC41-4163-9ECD-3DC3410F1EFB

Q35030572-4BE1B8DD-593D-45F7-A87E-3F716F5254AA

Q35030572-5860C261-57CB-4565-B339-C188905A4EC9

Q35030572-71B87A28-2A09-4EDD-BD19-0AD302E89A87

P304

Q35030572-E5464E58-0732-4F3F-803A-4C2C2F8E67B7

P31

Q35030572-2AAF51E6-3A07-4284-A1A7-54DB5780CCC1

P356

Q35030572-2E049F0C-4140-49A0-A0E8-B6B7AC1109E1

P433

Q35030572-A23B3A85-3255-4756-8119-480EFC927D61

P478

Q35030572-ABBC5122-8BC0-42F6-8322-DA8F887EA3C5

P50

Q35030572-46D6F1D2-81D9-4CB7-AB7E-19F49903B9F6

Q35030572-CB668486-A18E-4DA9-A419-03035E3FF779

Q35030572-F3294943-B227-46ED-BBA6-4E334ABAF01C

Q35030572-F7010BD8-B5E7-4188-9D94-2567F1657CF2

P577

Q35030572-E1D1A928-ED1E-4937-911A-99C1FEEC1996

P698

Q35030572-CEAB16D1-53D9-4683-B63B-4E32DE2CE66A

P921

Q35030572-B344D51F-8E7E-4975-8C25-9C0F5B81AC74

P932

Q35030572-9667095B-AE79-449C-BEAD-DC230D37AEBF

P356

P1433

Clinical Journal of the American Society of Nephrology

P1476

Inflammatory markers and risk of cerebrovascular events in patients initiating dialysis

@en

P2093

A Richey Sharrett

http://www.w3.org/2001/XMLSchema#string

Laura C Plantinga

http://www.w3.org/2001/XMLSchema#string

Nancy E Fink

http://www.w3.org/2001/XMLSchema#string

Neil R Powe

http://www.w3.org/2001/XMLSchema#string

Paige A Armstrong

http://www.w3.org/2001/XMLSchema#string

Rulan S Parekh

http://www.w3.org/2001/XMLSchema#string

P2860

Effect of statin therapy on C-reactive protein levels: the pravastatin inflammation/CRP evaluation (PRINCE): a randomized trial and cohort study

Novel clinical markers of vascular wall inflammation

Rosuvastatin to prevent vascular events in men and women with elevated C-reactive protein

Reduction of stroke events with pravastatin: the Prospective Pravastatin Pooling (PPP) Project.

Rosuvastatin and cardiovascular events in patients undergoing hemodialysis.

Relationship of interleukin-6 and tumor necrosis factor-alpha with muscle mass and muscle strength in elderly men and women: the Health ABC Study.

Stroke epidemiology: a review of population-based studies of incidence, prevalence, and case-fatality in the late 20th century.

Statin use and sepsis events [corrected] in patients with chronic kidney disease.

Chronic kidney disease: effects on the cardiovascular system.

Cerebrovascular disease incidence, characteristics, and outcomes in patients initiating dialysis: the choices for healthy outcomes in caring for ESRD (CHOICE) study.

P304

1292-1300

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.2215/CJN.08350910

http://www.w3.org/2001/XMLSchema#string

P433

6

http://www.w3.org/2001/XMLSchema#string

P478

6

http://www.w3.org/2001/XMLSchema#string

P50

Bernard G. Jaar

Stephen M. Sozio

J Craig Longenecker

P577

2011-05-05T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

21551022

http://www.w3.org/2001/XMLSchema#string

P921

P932

3109924

http://www.w3.org/2001/XMLSchema#string